AI assistant
Sending…
DEXCOM INC — Director's Dealing 2010
May 18, 2010
30198_dirs_2010-05-18_e1a3c339-24fe-4912-b0e1-ee605a8f3baa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2010-05-14
Reporting Person: LORD JONATHAN T MD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-14 | Common Stock | P | 300 | $10.69 | Acquired | 5411 | Direct |
| 2010-05-14 | Common Stock | P | 1300 | $10.695 | Acquired | 6711 | Direct |
| 2010-05-14 | Common Stock | P | 100 | $10.723 | Acquired | 6811 | Direct |
| 2010-05-14 | Common Stock | P | 4000 | $10.73 | Acquired | 10811 | Direct |
| 2010-05-14 | Common Stock | P | 300 | $10.735 | Acquired | 11111 | Direct |
| 2010-05-14 | Common Stock | P | 300 | $10.738 | Acquired | 11411 | Direct |
| 2010-05-14 | Common Stock | P | 400 | $10.74 | Acquired | 11811 | Direct |
| 2010-05-14 | Common Stock | P | 100 | $10.745 | Acquired | 11911 | Direct |
| 2010-05-14 | Common Stock | P | 200 | $10.748 | Acquired | 12111 | Direct |
| 2010-05-14 | Common Stock | P | 12920 | $10.75 | Acquired | 25031 | Direct |
| 2010-05-14 | Common Stock | P | 100 | $10.76 | Acquired | 25131 | Direct |
| 2010-05-14 | Common Stock | P | 100 | $10.77 | Acquired | 25231 | Direct |
| 2010-05-14 | Common Stock | P | 700 | $10.78 | Acquired | 25931 | Direct |
| 2010-05-14 | Common Stock | P | 100 | $10.79 | Acquired | 26031 | Direct |
| 2010-05-14 | Common Stock | P | 9002 | $10.8 | Acquired | 35033 | Direct |
| 2010-05-14 | Common Stock | P | 300 | $10.84 | Acquired | 35333 | Direct |
| 2010-05-14 | Common Stock | P | 9897 | $10.85 | Acquired | 45230 | Direct |
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17